Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin pilot study for prevention of mandibular relapse after mandibular advancement surgery
2011-003646-41Phase 2Completed
- Sponsor
- Oliver Ploder MD, DDS, PhD
- Start
- Nov 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in retrognathism, sponsored by Oliver Ploder MD, DDS, PhD. Started Nov 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
retrognathism
Beyond the preview
Go deeper on 2011-003646-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003646-41.